Under construction – not a live service
Sign in
Taking people in BelgiumPhase 2/3

Comparing two heart scans to tell apart certain brain diseases

Compares two heart imaging scans in people with Parkinson's, Lewy body dementia or related conditions.

Key facts

Who runs it
UZ Leuven
Where
Gent and Leuven, BelgiumSee the 2 sites
Registry title
Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease.
Status
Recruiting
Phase
Phase 2/3
People taking part
113 people, planned
Started
19 Jan 2024
Expected to end
31 Dec 2026
Type of study
Interventional
Record updated
24 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Parkinson's disease, multiple system atrophy, dementia with Lewy bodies or Alzheimer's disease. It compares two heart scans, [18F]-MFBG PET and [123I]-MIBG SPECT, to tell these diseases apart.

Age
18 years or older.
Sex
Women and men can join.

Where in Belgium

  • Universitair Ziekenhuis GentGent, BelgiumTaking people
  • UZ LeuvenLeuven, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Comparing two heart scans to tell apart certain brain diseasesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
24 June 2026